You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your country.
The content on this site may not be allowed under the laws of your country of residence. Please review the applicable healthcare laws in your country. If not allowed, please exit this site. Medtronic declines any liability as to your access to such information.
Click “Continue” to close this window and view the site’s content.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic, Inc. (“Medtronic”) offers RemoteView, which permits a user (“Programmer User”) of the Medtronic CareLink® 2090 Programmer (“Programmer”) to allow the viewing of information presently displayed on the Programmer screen with one or more individuals in remote locations anywhere in the world (“Remote Viewer”), including remote health care professionals or Medtronic representatives.
Limited License Grant. You are hereby granted a nonexclusive, nontransferable, terminable, nonassignable, nonsublicensable, limited license to install and use a copy of the Licensed Software solely for authorized and legitimate purposes. You may not otherwise copy, use, modify, reverse engineer, decompile, disassemble, create derivative works based on, or integrate with other systems or programs the Licensed Software without the prior written consent of Medtronic. You shall have sole responsibility for any fees or charges, including service or data charges, incurred by you in connection with your use of the Licensed Software. You shall not remove any proprietary or other legend or restrictive notice contained or included in the Licensed Software or other documentation associated with such Licensed Software. You agree to maintain any and all copyright, trademark, and other notices on the Licensed Software and any associated documentation.
Licensed Software Functionality and Data Use, Collection, Viewing, and Transfer.
“Active Remote Viewer” as referred to herein shall mean a Remote Viewer that has installed the Licensed Software and has at the relevant point in time an active network connection to a Medtronic server via the Licensed Software.
By installing or using the Licensed Software or clicking any acceptance button in connection with this Agreement, you acknowledge, understand, agree to, and consent to all of the following, including when you are an Active Remoter User:
) Registration. To obtain access to the Licensed Software, you must register at the Medtronic RemoteView website and establish a user name and password. All information that you provide in connection with such registration must be complete, accurate, and truthful. The user name and password are personal to you and must not be shared with anyone else. You will also not attempt, directly or indirectly, to disable, bypass, or defeat any password protection associated with the Licensed Software. Medtronic reserves the right to deny or disable any user name or password or request for any user name or password.
) Your Personal Information. Medtronic will collect information in connection with your registration and installation and use of the Licensed Software, including your first and last name, your email address, a selected security question(s) and your corresponding answer(s), your address, and your telephone number. You agree that Medtronic may store this personal information about you on a Medtronic server, including a server located in the United States of America.
) Session Key. To view the information on the Programmer, the Remote Viewer must generate a Session Key that must be shared with and entered by the Programmer User. “Session Key” as used herein means a unique token active for a limited period of time generated by the Remote Viewer. You agree not to share this Session Key with anyone other than the Programmer User who has initiated the specific session.
) Logging of Session Activity. Each time you log in to the Licensed Software, Medtronic will collect information about your activity, including in an aggregated log or database, regarding you and your session, including your name, username, computer name, IP address, operating system details, and session details (including transferring and sharing activity, start and end times, view only or control activity, and any chat messages between or among any Active Remote Viewers. You agree that Medtronic may store any personal information about you on a Medtronic server, including a server located in the United States of America.
) Active Remote Users. When you are an Active Remote Viewer: (1) you will be able to view the name and/or user name of any other Active Remote Viewer who is logged into the same Medtronic server; and (2) any other Active Remote Viewer who is actively logged into the same Medtronic server will be able to view your name and/or user name. The Licensed Software also permits one Active Remote Viewer to share the information being viewed to any other Active Remote Viewer. You must not share any information from the Medtronic programmer, including with any other Active Remote Viewer, absent the express permission from the Programmer User that is allowing you to view the information.
) Availability. Medtronic has limitations on the number of users that can concurrently log in to the Licensed Software at any given time. Thus, installation of or accessing the Licensed Software does not guarantee that it will be available to you for use at any time.
Permissions. By installing and using the Licensed Software, you represent that you have permission to do so from any associated clinic, hospital, or medical practice and that your use of the Licensed Software complies with any policies or requirements of such associated clinic, hospital, or medical practice. You are also responsible for confirming that the Programmer User has obtained any necessary patient consent before allowing you to view any patient information via the Licensed Software.
Your Acknowledgements. You acknowledge that the Licensed Software is not the exclusive method of viewing information from the Programmer and that the Licensed Software is not the exclusive method by which to obtain a patient’s implanted cardiac device data, including any data on the Programmer. You also acknowledge that the Licensed Software is not intended to be used as a life-sustaining or interventional tool during medical emergencies. You further acknowledge that Medtronic is not, and shall not be deemed to be, a provider of patient health care services by virtue of its provision of access to the Programmer screen information via the Licensed Software. You also acknowledge that information from the Licensed Software is not an electronic medical record and use of the Licensed Software does not in any way relieve you from using your best medical judgment to determine a proper course of treatment for patients.
Security/Privacy of Patient Data. Your use of the Licensed Software and any Session Keys shall be solely for legitimate and lawful purposes and not for any malicious purpose. You are solely responsible for and will use your best efforts in maintaining the confidentiality and security of any copies of the Licensed Software as well as any user name, password credentials, and any Session Keys that can be used in accessing the Licensed Software, a Medtronic server, or any information from a Programmer. You are solely responsible for and will use your best efforts in keeping any patient information you may receive or view in connection with the Licensed Software confidential and secure, and you will not attempt to capture or copy any patient information you view in any electronic or hard copy format without the express permission of the Programmer User. You will be responsible for any obligations or liabilities associated with any lost, stolen, or otherwise compromised patient information.
Reporting Issues and Feedback. You agree that you will report any issues or questions, technical or otherwise, regarding the Licensed Software promptly and directly to Medtronic. If you submit any comments or ideas to Medtronic, in the absence of a separate agreement regarding such submissions, you grant to Medtronic an unrestricted, royalty-free, irrevocable license to use, reproduce, display, perform, modify, transmit, and distribute such ideas in any medium and agree that Medtronic is free to use them for any purpose. In addition, Medtronic has no obligation to provide continued maintenance and support to you in connection with the Licensed Software. Any maintenance and support services provided by Medtronic shall be at Medtronic’s sole discretion.
Limitations of Liability.
THE LICENSED SOFTWARE IS PROVIDED TO YOU “AS IS,” AND MEDTRONIC EXPRESSLY DISCLAIMS ANY AND ALL WARRANTIES WITH RESPECT TO THE LICENSED SOFTWARE AND YOUR USE THEREOF, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NONINFRINGEMENT. MEDTRONIC DOES NOT WARRANT THAT THE USE OF THE LICENSED SOFTWARE WILL BE UNINTERRUPTED OR ERROR-FREE.
Legal Compliance. You shall at all times use the Licensed Software in compliance with all applicable laws. You shall ensure that your installation and use of the Licensed Software complies with all applicable export and import laws, regulations, orders, and policies of the United States of America and any other applicable jurisdiction. You represent and warrant that (i) you are not located in a country that is subject to a U.S. Government embargo, or that has been designated by the U.S. Government as a “terrorist supporting” country, and (ii) you are not listed on any U.S. Government list of prohibited or restricted parties.
Term, Termination, Modifications, and Support. This Agreement shall be in effect from the date when you first install or use the Licensed Software. Medtronic may modify, amend, or terminate this Agreement at any time, including by providing notices or an updated version of this Agreement on a Medtronic website. Medtronic may modify, disable, or terminate your use or Medtronic’s support of the Licensed Software at any time, including by providing notices on a Medtronic website. All obligations which are ongoing in nature shall survive termination or expiration of this Agreement. At any time upon Medtronic’s request (including via a notice on a Medtronic website), you agree to promptly delete and terminate use of any and all copies of the Licensed Software. In addition, upon Medtronic’s request, you agree to provide written verification that you have destroyed all copies of the Licensed Software together with the manner, date, and time of such destruction.
NayaMed International Sárl Customers: Whether the RemoteView feature shall be used in connection with NayaMed customers or devices shall be solely within the discretion of NayaMed International Sárl. If the Licensed Software is used connection with NayaMed customers or devices, this Agreement shall be directly between you and NayaMed with respect to those uses.
New Zealand ranks as one of the highest-performing countries in the Organisation for Economic Cooperation and Development’s (OECD) Better Life Index, scoring 7.3 on general life satisfaction on a scale from 0 to 10, higher than the OECD average of 6.5.1 A big reason for such a high quality of life is a high-quality healthcare system in which 88% of people in New Zealand report good health — one of the top scores across the OECD and far better than the average of 69%.
What sets the country apart? Overall, New Zealand produces good health outcomes for the level of investment in the system, notes Ann-Marie Cavanagh, acting deputy director general, data and digital at New Zealand’s Ministry of Health. In particular, the nation has strong policies and frameworks in place, including the 2016 New Zealand Health Strategy, a ten-year plan that views strong investment in healthcare as a necessary means to improving the overall wellbeing of New Zealanders.
The health ministry’s “Triple Aim Framework”2 is one way in which the government hopes to accomplish this goal by 2026. The framework acts as a three-pronged approach to delivering high-performance and value in healthcare. It seeks to provide:
The ministry’s emphasis on value acknowledges that, in order to deliver an improved healthcare service, an array of factors ranging from economic means to users’ experience determine the quality of care. Moreover, it recognises that value must be dispersed equally. Population groups such as Māori and Pacific peoples often receive a reduced form of healthcare services in New Zealand. The ministry is clear that improving the health of such groups may involve tailoring services to be more accessible, or that services are provided bearing cultural distinctions in mind.
The nation has strong policies and frameworks in place, including the 2016 New Zealand Health Strategy, a ten-year plan that views strong investment in healthcare as a necessary means to improving the overall wellbeing of New Zealanders.
The ten-year plan also emphasises the use of data and technology in delivering better value and care. Smart System, a theme within the ministry’s roadmap, highlights how data and smart information systems can help to boost the availability of accurate information at the point of care, develop individual online health records that people can access and contribute to, and enhance decision-making and management reporting. Data collection and progress tracking in particular are two core components of how a smart healthcare system can advance the value of national healthcare provision. In order to implement this type of system, the Ministry of Health also established Digital Health 2020 to guide investments in digital across the health and disability sector in 2016-20.
“We’re in the business of creating positive outcomes for patients and populations. Why not measure it and put this information in front of decision-makers so we can get more for your healthcare dollars,” says Marc ter Beek, chief data officer at the Waikato District Health Board (DHB), one of New Zealand’s 20 regional health boards.
New Zealand’s digital strategy aims to connect technological investment with value delivery. Featuring five central components, it intends to create:
As each of these initiatives advance at different stages, monthly reports by the Ministry provide updates on key milestones. The September 2018 report, for instance, noted that 61% of general practices have implemented patient portals to offer their patients online access to their health information, and that New Zealand’s ePrescription Service is on the upswing, used by approximately one-tenth of GPs.3 In addition to information on progress, each report sets out details on upcoming milestones and the key risk factors involved.
The creation of a health and wellness dataset requires IT infrastructure that can securely share data between social sector government agencies and some non-government organisations. The National Patient Flow service is an example of a platform that provides information on patient referrals for specialist services, the outcome of these referrals and the time it takes patients to access care.
“New Zealand is developing a digital health strategy that is focused on enablers such as interoperability of systems, technical standards and creating a digital ecosystem that ensures appropriate data can be shared. One of the foundational principles is that digital services should be both consumer and life centred,” explains Ms Cavanagh.
New Zealand is also working to improve healthcare through the use of crowdsourced data to tackle common problems. For example, in 2018 the Ministry of Health announced that it would work together with Australia to establish its FluTracking initiative4 in New Zealand. The tracking initiative, an online health monitoring system designed to track flu-like symptoms across the country, was originally established in Australia in 2006. It consists of a simple online survey that takes less than ten seconds to complete each week during the flu season. The data are compiled into a report that discloses respondent numbers by jurisdiction, the types of symptoms experienced and the number of those vaccinated and unvaccinated.
Having this data helps inform healthcare practitioners, citizens and other stakeholders on important yet simple matters such as the prevalence of influenza strains in a given season. Should one particular area of New Zealand experience worse cases of flu compared with others, the tracking system could be used as a basis to analyse external factors contributing to health problems such as the environment, housing and economic means. And the basis of this initiative has the potential to be used throughout the healthcare sector. For example, crowdsourced data could be used to understand other common patient trends such as the use of primary care and emergency services and how those correlate with external factors such as geography and economic status.
Another element adding to New Zealand’s digital capabilities is its Integrated Data Infrastructure (IDI). The research database, developed by Statistics New Zealand, collates information about people and households with input from numerous government agencies as well as non-governmental organisations. The data mainly centre around issues such as education, income, benefits, migration, justice and health. That information is linked together to form the IDI with the purpose of giving researchers insight into New Zealand’s economy and society. The Ministry of Health can then provide information that underpins broad societal topics such as mental health and addiction, maternity care, and cancer, among others.
Interactive communication between people and healthcare providers not only helps governments make evidence-based decisions regarding policy, but also provides a wealth of information that can be used to assess socio-economic evolvement and wellbeing.
For example, one study, called “Improving rates of overweight, obesity and extreme obesity in New Zealand 4-year-old children in 2010–2016”, involved collecting height and weight data. The results showed that the prevalence of overweight, obesity and extreme obesity decreased by 2.2%, 2.0% and 0.6% respectively between 2010/11 and 2015/16. These downward trends remained after adjustments for sex, ethnicity, deprivation, and urban and rural residence.5 Such studies add considerable context, which then allows for the assessment of aspects of societal behaviour ranging from eating patterns and nutrition education levels, to trends in population groups in both rural and urban environments.
In addition to strong data collection, healthcare professionals in New Zealand are also making strides in data analysis. For example, says Mr ter Beek, his DHB has been making use of Qlik, a data analytics platform, to look at large quantities of data such as on trauma incidents. With Qlik, the analysts can create data visualisations and examine correlations such as between data on motorbike accidents and road conditions to start predicting where accidents might occur and what type of patient they may need to treat.
New Zealand’s 2016 Health Strategy is an effective example of how countries can benefit from the resourceful use of data and technology to improve value in their healthcare systems. And interactive communication between people and healthcare providers not only helps governments make evidence-based decisions regarding policy, but also provides a wealth of information that can be used to assess socio-economic evolvement and wellbeing.
Still, while being a sound strategy, the plan needs proper investment and an implementation approach to meet its full potential, notes Mr ter Beek. Currently, the system is in the early days of realising the promise of the Health Strategy. For example, many healthcare professionals are still keeping a lot of paper records, says Mr ter Beek, so implementing a move toward standardised and patient accessible electronic health records would help operationally and significantly enrich analysis. He would also like to see more standardisation and a unified effort across the country to track health outcomes data and costing data that fully account for provider time and other costs, in order to get a more holistic and specific view of value.
“Agreeing and capturing standard health outcomes measures, developing a single electronic health record and other IT initiatives, and attracting and retaining the required population health and data analytics talent are all challenges in a fragmented DHB environment,” adds Mr ter Beek. “I would advocate for centralisation of population health, funding, IT and business intelligence as a start.” This will enable clear evidence-based decision-making about funded services, considering the trade-offs between prevention, early intervention and hospital-based interventions for all health funds available for the population.
But the country appears to be trending in the right direction. The use of agile technology and accessible social platforms in New Zealand will enable the Ministry of Health to frequently examine the success of its initiatives and assess what can be improved. And DHBs theoretically have the flexibility to experiment with value-based healthcare models, although New Zealand’s single-payer system tends to prioritise volume, including population size, in allocating to DHBs.
“Whilst there is population-based funding, the current funding contracts are still very much volume based, and there exist many other volume-based performance targets for DHBs,” says Mr ter Beek. “I call them ‘misincentives’ as they create, as a minimum, a perception that DHBs do not receive all their funding if they do not hit certain volume targets, specifically for electives. In primary care, co-payments for patients have a similar effect. Our DHB is on a journey to create more outcome-focused contracting models through a commissioning approach.”
Mr ter Beek also advocates for keeping improvement capability and capacity decentralised to allow organisations and other decision-makers (clinicians, funders and managers) to review their own performance and make better value-based decisions at the local level. Value-based healthcare decision-making should be promoted and enabled at all levels in the system.
A case study from The Economist Intelligence Unit commissioned by Medtronic.
OECD; Better Life Index; New Zealand; http://www.oecdbetterlifeindex.org/countries/new-zealand/
Ministry of Health; New Zealand Health Strategy; Value and High Performance; https://www.health.govt.nz/new-zealand-health-system/new-zealand-health-strategy-future-direction/five-strategic-themes/value-and-high-performance
Ministry of Health; Monthly reports on digital health initiatives; https://www.health.govt.nz/system/files/documents/pages/digital-health-portfolio-report-sept2018.pdf
Statistics New Zealand; Improving rates of overweight, obesity and extreme obesity in New Zealand 4-year-old children in 2010–2016; 2017; https://cdm20045.contentdm.oclc.org/digital/collection/p20045coll17/id/715/rec/19
Disclaimer: This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorization for use.